KORU Medical Systems (KRMD) Competitors $3.34 -0.14 (-4.02%) As of 01:02 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock KRMD vs. EMBC, BBNX, AVNS, BVS, KIDS, RXST, AXGN, BFLY, SMLR, and DCTHShould you be buying KORU Medical Systems stock or one of its competitors? The main competitors of KORU Medical Systems include Embecta (EMBC), Beta Bionics (BBNX), AVANOS MEDICAL (AVNS), Bioventus (BVS), OrthoPediatrics (KIDS), RxSight (RXST), AxoGen (AXGN), Butterfly Network (BFLY), Semler Scientific (SMLR), and Delcath Systems (DCTH). These companies are all part of the "medical equipment" industry. KORU Medical Systems vs. Its Competitors Embecta Beta Bionics AVANOS MEDICAL Bioventus OrthoPediatrics RxSight AxoGen Butterfly Network Semler Scientific Delcath Systems KORU Medical Systems (NASDAQ:KRMD) and Embecta (NASDAQ:EMBC) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, earnings, profitability, dividends, analyst recommendations, risk, media sentiment and institutional ownership. Does the media refer more to KRMD or EMBC? In the previous week, Embecta had 1 more articles in the media than KORU Medical Systems. MarketBeat recorded 4 mentions for Embecta and 3 mentions for KORU Medical Systems. Embecta's average media sentiment score of 1.50 beat KORU Medical Systems' score of 0.62 indicating that Embecta is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment KORU Medical Systems 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Embecta 2 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Do analysts prefer KRMD or EMBC? KORU Medical Systems currently has a consensus price target of $4.50, suggesting a potential upside of 34.73%. Embecta has a consensus price target of $19.33, suggesting a potential upside of 85.72%. Given Embecta's higher probable upside, analysts plainly believe Embecta is more favorable than KORU Medical Systems.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score KORU Medical Systems 0 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 1 Strong Buy rating(s) 3.00Embecta 0 Sell rating(s) 2 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.33 Which has preferable valuation & earnings, KRMD or EMBC? Embecta has higher revenue and earnings than KORU Medical Systems. KORU Medical Systems is trading at a lower price-to-earnings ratio than Embecta, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioKORU Medical Systems$33.65M4.58-$6.07M-$0.11-30.36Embecta$1.08B0.56$78.30M$0.9011.57 Which has more risk & volatility, KRMD or EMBC? KORU Medical Systems has a beta of 0.52, meaning that its share price is 48% less volatile than the S&P 500. Comparatively, Embecta has a beta of 1.08, meaning that its share price is 8% more volatile than the S&P 500. Do insiders & institutionals have more ownership in KRMD or EMBC? 58.6% of KORU Medical Systems shares are owned by institutional investors. Comparatively, 93.8% of Embecta shares are owned by institutional investors. 20.6% of KORU Medical Systems shares are owned by company insiders. Comparatively, 0.4% of Embecta shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Is KRMD or EMBC more profitable? Embecta has a net margin of 4.89% compared to KORU Medical Systems' net margin of -15.09%. Embecta's return on equity of -19.67% beat KORU Medical Systems' return on equity.Company Net Margins Return on Equity Return on Assets KORU Medical Systems-15.09% -30.43% -19.41% Embecta 4.89%-19.67%12.27% SummaryEmbecta beats KORU Medical Systems on 12 of the 17 factors compared between the two stocks. Get KORU Medical Systems News Delivered to You Automatically Sign up to receive the latest news and ratings for KRMD and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding KRMD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart KRMD vs. The Competition Export to ExcelMetricKORU Medical SystemsMEDICAL INFO SYS IndustryMedical SectorNASDAQ ExchangeMarket Cap$154.11M$2.00B$5.54B$9.13BDividend YieldN/AN/A5.06%4.01%P/E Ratio-30.3634.7628.2819.59Price / Sales4.5811.51373.0879.85Price / CashN/A54.0224.7227.50Price / Book9.038.568.275.54Net Income-$6.07M-$62.39M$3.19B$252.38M7 Day Performance-8.99%4.87%5.55%3.04%1 Month Performance3.41%11.04%9.36%11.67%1 Year Performance26.04%6.13%30.22%17.14% KORU Medical Systems Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)KRMDKORU Medical Systems2.6816 of 5 stars$3.34-4.0%$4.50+34.7%+31.3%$154.11M$33.65M-30.3680EMBCEmbecta4.7495 of 5 stars$10.03-2.8%$19.33+92.8%-20.5%$603.13M$1.08B11.142,100Positive NewsBBNXBeta BionicsN/A$13.40-0.9%$23.44+75.0%N/A$586.18M$65.12M0.00294Positive NewsAVNSAVANOS MEDICAL2.8224 of 5 stars$11.87-3.9%N/A-43.3%$571.11M$687.80M-1.422,227Negative NewsBVSBioventus2.9777 of 5 stars$6.82-2.8%$13.75+101.6%+6.4%$560.22M$567.70M-11.181,200KIDSOrthoPediatrics4.2827 of 5 stars$21.24-5.5%$35.83+68.7%-33.2%$545.96M$204.73M-12.14200Positive NewsRXSTRxSight2.231 of 5 stars$12.43-4.8%$37.90+204.9%-83.2%$530.31M$139.93M-18.55220Analyst DowngradeAXGNAxoGen2.3226 of 5 stars$11.36+3.9%$24.50+115.7%+43.9%$497.80M$187.34M-75.73450High Trading VolumeBFLYButterfly Network2.4552 of 5 stars$1.89-2.6%$3.50+85.2%+54.7%$479.74M$82.06M-6.52460Options VolumeSMLRSemler Scientific2.584 of 5 stars$38.95-3.7%$71.00+82.3%+35.8%$451.08M$56.29M-14.92120DCTHDelcath Systems2.4183 of 5 stars$12.24-3.5%$24.00+96.1%+40.5%$441.94M$37.21M-24.4860 Related Companies and Tools Related Companies EMBC Competitors BBNX Competitors AVNS Competitors BVS Competitors KIDS Competitors RXST Competitors AXGN Competitors BFLY Competitors SMLR Competitors DCTH Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:KRMD) was last updated on 7/14/2025 by MarketBeat.com Staff From Our PartnersYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredCentral Banks Are Hoarding Gold – Should You?The AI boom isn’t just transforming technology—it’s redefining global power, increasing government debt, and u...Lear Capital | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding KORU Medical Systems, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share KORU Medical Systems With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.